How many insider trades does FilingIQ track for NPHC?

FilingIQ tracks 7 Form 4 insider transactions for NPHC (NUTRA PHARMA CORP), covering filings from Jun 26, 2018 onwards. 1 of those are dated within the last 90 days.

Are NPHC insiders net buyers or net sellers?

Across the full Form 4 history for NPHC, 3 transactions (43%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does NPHC insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ links every filing to the insider's SEC CIK, marks plan trades, tax withholding, option exercises, gifts, derivatives and amendments, and shows each open-market purchase and sale with the same fixed facts. It does not rate the stock.

What sector is NPHC in?

NUTRA PHARMA CORP (NPHC) is classified in the Healthcare sector, specifically Drug Manufacturers - Specialty & Generic, with a current market capitalisation of $1.42M.

NPHC insider trading

Healthcare

NUTRA PHARMA CORP: insider trade history from SEC Form 4 filings.

Total Form 4 trades

Last 90 days

Buys / sells

43% / 0%

Market cap

$1.42M

About NUTRA PHARMA CORP

Nutra Pharma Corp., a biopharmaceutical company, acquires, licenses, and commercializes pharmaceutical products and technologies, and drugs for the management of pain, neurological disorders, cancer, and autoimmune and infectious diseases in the United States. The company offers Nyloxin, an over-the-counter (OTC) pain reliever; Nyloxin Extra Strength, a non-narcotic and non-addictive treatment for severe pain; Pet Pain-Away, an OTC pain reliver for dogs and cats; Equine Pain-Away, an OTC topical pain reliever to relieve pain in horses; and Luxury Feet, an OTC pain reliever for foot pain from high heels and stilettos. It is also involved in developing RPI-78M to treat neurological and autoimmune diseases, including multiple sclerosis, adrenomyeloneuropathy, amyotrophic lateral sclerosis, rheumatoid arthritis, and myasthenia gravis; RPI-MN to treat viral diseases comprising human immunodeficiency virus/AIDS and herpes, and general anti-viral applications; RPI-78 for pain and arthritis; and RPI-70 for pain. The company was incorporated in 2000 and is based in Boca Raton, Florida.

Company website: www.nutrapharma.com

NPHC insider activity at a glance

FilingIQ tracks 7 insider transactions for NPHC in filings since Jun 26, 2018. The most recent transaction is dated Aug 21, 2026.

Across the full history, 3 open-market purchases and 0 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

How FilingIQ classifies each line, and the seven facts it shows on every open-market purchase and sale, are documented on the methodology page.

View live NPHC trades on FilingIQ Raw filings on SEC EDGAR

Latest NPHC Form 4 filings

DEITSCH RIK J

G Sep 1, 2026

DEITSCH RIK J President, CEO

PA Jun 26, 2018

Most recent disclosures. Sign up to filter by transaction code, insider role or dollar value.

Other Healthcare tickers with recent insider activity

UTHR 844

UNITED THERAPEUTICS Corp

THERMO FISHER SCIENTIFIC INC.

ATTO 123

Attovia Therapeutics, Inc.

TEM 104

Tempus AI, Inc.

CORT 103

CORCEPT THERAPEUTICS INC

CSTL 97

CASTLE BIOSCIENCES INC

Frequently asked

How many insider trades does FilingIQ track for NPHC?: FilingIQ tracks 7 Form 4 insider transactions for NPHC (NUTRA PHARMA CORP), covering filings from Jun 26, 2018 onwards. 1 of those are dated within the last 90 days.
Are NPHC insiders net buyers or net sellers?: Across the full Form 4 history for NPHC, 3 transactions (43%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does NPHC insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ links every filing to the insider's SEC CIK, marks plan trades, tax withholding, option exercises, gifts, derivatives and amendments, and shows each open-market purchase and sale with the same fixed facts. It does not rate the stock.
What sector is NPHC in?: NUTRA PHARMA CORP (NPHC) is classified in the Healthcare sector, specifically Drug Manufacturers - Specialty & Generic, with a current market capitalisation of $1.42M.

Methodology & sources

Every NPHC insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). How lines are classified and which facts FilingIQ adds is documented on the methodology page; the people behind it are on the team page. Not investment advice; see disclaimer.